Implantable cardioverter defibrillators for primary prevention in cardiomyopathies

Area of Science:

• Cardiology
• Electrophysiology
• Medical Device Technology

Background:

• Implantable cardioverter defibrillators (ICDs) are utilized for primary prevention of sudden cardiac death (SCD) in young individuals.
• This study focuses on the real-world outcomes of ICDs in the Indian population, specifically analyzing therapy efficacy and safety.

Purpose of the Study:

• To evaluate the incidence of appropriate ICD therapies in patients with cardiomyopathy receiving ICDs for primary prevention.
• To assess the rates of inappropriate therapies and complications associated with ICD implantation in this cohort.
• To identify predictors of appropriate ICD therapy through correlation and regression analyses.

Main Methods:

• Retrospective analysis of patients with cardiomyopathy who underwent ICD implantation for primary prevention.
• Review of ICD interrogations and stored electrograms to analyze therapy delivery and underlying arrhythmias.
• Statistical analysis including correlation and regression to determine predictors of appropriate therapy.

Main Results:

• A total of 50 patients were followed for a mean of 4.4 years (220.2 patient-years).
• Appropriate ICD therapy was delivered to 32% of patients (29.5 events per 100 patient-years).
• Inappropriate therapy occurred in 14% of patients (19.9 events per 100 patient-years), and complications in 16% (3.6 events per 100 patient-years).

Conclusions:

• Appropriate ICD therapy was observed in 32% of patients with cardiomyopathy receiving ICDs for primary prevention over a mean follow-up of 4.4 years.
• Inappropriate therapies (14%) and complications (16%) were common, underscoring the importance of careful patient selection and device management.